To provide a new compound that is based on a phosphodiesterase 10A(PDE10A) inhibitory action and is useful for preventing or treating psychotic disorders (integration dysfunction syndrome, integration dysfunction syndrome type disorder, delusional disorder, drug-induced psychosis, etc.), disordered mood (major depression disorder, bipolar disorder, schizoaffective disorder, etc.), anxiety disorder (panic disorder, social anxiety disorder, obsessive-compulsive disorder, posttraumatic stress disorder, acute stress disorder, generalized anxiety disorder, etc.), cognitive dysfunction (Alzheimer's disease, dementia, attention-deficit hyperactivity disorder, etc.), disorder of movement (Parkinson's disease, Huntington's disease, restless legs syndrome, etc.), drug or alcohol dependence disease, eating disorder (binge eating, anorexia, etc.), sleep arousal disorder, metabolic disease (diabetes, abnormal glucose tolerance, obesity, metabolic syndrome, etc.), ache or cancer or a pharmaceutically acceptable salt thereof.
A compound is represented by formula (I) or a pharmaceutically acceptable salt thereof.
AMADA HIDEAKI
MIYAKOSHI NAOKI
TAMIDA TOMOKO
KASHIWA SHUHEI
Next Patent: STABILIZATION METHOD